Go to the list of all blogs
Serhii Bondarenko's Avatar
published in Blogs
Sep 25, 2026
Navigating IWM's Recent -5.6% Pullback Amid 2026 Small-Cap Shifts

Navigating IWM's Recent -5.6% Pullback Amid 2026 Small-Cap Shifts

Key Takeaways

  • IWM is a passively managed ETF tracking the Russell 2000 Index, providing broad exposure to roughly 2,000 U.S. small-capitalization stocks.
  • The fund's largest sector allocations are Health Care, Financials, Industrials, and Information Technology, with no single holding exceeding about 1% of assets.
  • After leading U.S. equities through much of 2026, small caps have pulled back in recent weeks as rising Treasury yields and a more hawkish Federal Reserve stance pressured rate-sensitive companies.
  • IWM is down approximately 5.6% over the trailing 30 days, while retaining a double-digit gain on a year-to-date basis.
  • The principal opportunities center on earnings breadth, AI infrastructure spending, and mergers and acquisitions (M&A), while the key risk remains interest-rate sensitivity.

IWM ETF Basics and Portfolio Composition

The iShares Russell 2000 ETF seeks to track the investment results of the Russell 2000 Index, a float-adjusted, market-capitalization-weighted benchmark of the roughly 2,000 smallest companies in the broader Russell 3000 Index. Launched in May 2000 and sponsored by BlackRock, the fund is among the largest and most liquid vehicles for U.S. small-cap exposure, with net assets of approximately $80 billion and about 2,000 individual holdings.

IWM is a passive, non-leveraged, non-inverse fund with an expense ratio of 0.19% and a trailing 12-month dividend yield near 0.9%. Its diversified structure means no single stock dominates the portfolio: even the largest holding typically represents around 1% of assets, and the top ten positions collectively account for only a low-single-digit share of the fund. Top holdings have recently included Bloom Energy (BE), Credo Technology (CRDO), Fabrinet (FN), and Coeur Mining (CDE). I also checked sector weights using Tickeron’s AI Screener to confirm the fund's broad domestic focus.

Sector exposure is broad and domestically oriented. Health Care and Financials each account for roughly 20% of the portfolio, followed by Industrials (about 14%) and Information Technology (about 13%). Consumer Discretionary, Energy, Real Estate, and Materials round out the allocation. Because most Russell 2000 companies derive the majority of their revenue inside the United States, IWM is effectively a proxy for the health of the domestic economy rather than global trade flows.

Small-Cap Themes and Market Dynamics

The small-cap environment has been shaped by two opposing forces in recent months. On one side, a broadening earnings recovery and attractive relative valuations supported a prolonged period of small-cap outperformance. The Russell 2000 advanced roughly 14% to 15% year-to-date in 2026, outpacing large-cap benchmarks for much of the year as investors rotated away from concentrated mega-cap technology positions. From what I see, AI infrastructure spending has extended benefits to smaller suppliers in power generation and precision components.

Several structural themes have reinforced this trend. Artificial intelligence (AI) spending has migrated down the supply chain, benefiting smaller suppliers of power generation, electrical equipment, cooling systems, and precision manufacturing components. Defense procurement, reshoring, and infrastructure investment have likewise flowed to specialized small-cap industrial and engineering firms. Biotechnology and healthcare names have contributed through clinical data readouts and corporate activity, while robust M&A has provided an additional route to value realization across the small-cap universe.

On the other side, monetary policy has emerged as a significant headwind. A more hawkish Federal Reserve, combined with elevated longer-dated Treasury yields that briefly tested 5%, has raised financing costs for smaller companies, which typically rely more heavily on external borrowing than their large-cap counterparts.

Recent Performance Trends for IWM

IWM's recent trajectory reflects this tension between improving fundamentals and tightening financial conditions. After setting intraday highs during the summer and posting a sizable year-to-date advance, the fund has consolidated and pulled back in recent weeks. Over the trailing 30 days, IWM has declined roughly 5.6%, while remaining comfortably positive on a year-to-date basis. One thing that stands out is how the pullback stems more from rate pressures than from earnings deterioration.

The pullback has been driven primarily by the rise in interest rates rather than deteriorating earnings. The fund's high correlation to long-duration Treasury prices has been a defining feature of the period, with small-cap performance moving closely alongside falling bond prices. Regional banks and other financial holdings have felt the squeeze from a steeper yield curve and shifting rate expectations, while rate-sensitive sectors across the portfolio have absorbed the bulk of the selling pressure.

Notably, the drawdown has been broad rather than concentrated, consistent with a fund whose largest individual position is only about 1% of assets. Company-specific catalysts have continued to generate outsized single-stock moves, but the index-level weakness has been a function of macro positioning and sector rotation rather than a handful of failing holdings. I’m watching this closely as earnings breadth evolves.

Key Factors for the Remainder of 2026

The direction of interest rates is likely to remain the single most important variable for IWM through the balance of 2026. Persistently elevated Treasury yields and any further tightening by the Federal Reserve would pressure the many small companies that depend on external financing, while a stabilization or decline in yields could relieve a major source of valuation compression.

Beyond monetary policy, investors should monitor the durability of the small-cap earnings recovery. If earnings breadth continues to broaden and operating leverage translates into accelerating profit growth, the fundamental case for small caps could remain intact even amid rate volatility. The AI infrastructure buildout, defense spending, and reshoring trends are additional structural drivers worth watching, as they disproportionately benefit specialized industrial and technology suppliers within the index.

Other factors include M&A activity, which can unlock value in discounted small-cap assets; the path of inflation and labor-market data, which will shape the Fed's policy stance; and the seasonal and technical dynamics that have historically made the autumn months more challenging for small-cap equities. Capital flows into small-cap ETFs and the pace of sector rotation between large-cap growth and small-cap value will also influence the fund's near-term performance. These themes frame the opportunity set and the risks, without constituting a forecast of future returns.

Using AI Tools for ETF Analysis

In my analysis of small-cap trends, I often rely on Tickeron’s AI Screener to scan for momentum shifts and sector rotations across thousands of securities. It surfaces technical patterns, fundamentals, and AI signals that complement a broader view of funds like IWM. This approach helps identify emerging opportunities without extensive manual work, especially when monitoring rate-sensitive names and thematic drivers in the Russell 2000 space.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: IWM

Contributor

Serhii Bondarenko is an AI-focused trading strategist and financial markets analyst specializing in the development and application of AI trading bots and autonomous trading agents. His work combines technical analysis, fundamental analysis, and quantitative research to identify market patterns, forecast price movements, and analyze liquidity, volatility, and correlations across global stock markets. Serhii actively publishes market insights, forecasts, and trading frameworks on platforms such as Investing.com and Finextra, with a strong focus on AI-driven decision-making and next-generation algorithmic trading. His research aims to bridge the gap between traditional trading methodologies and advanced artificial intelligence, helping traders and investors navigate complex and rapidly evolving market conditions.


IWM in downward trend: 10-day moving average crossed below 50-day moving average on September 02, 2026

The 10-day moving average for IWM crossed bearishly below the 50-day moving average on September 02, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 20, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IWM as a result. In 72 of 93 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 77%.

The Moving Average Convergence Divergence Histogram (MACD) for IWM turned negative on August 20, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 35 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 80%.

IWM moved below its 50-day moving average on August 28, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IWM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.

The Aroon Indicator for IWM entered a downward trend on September 24, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where IWM's RSI Oscillator exited the oversold zone, 24 of 26 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Following a +1.09% 3-day Advance, the price is estimated to grow further. Considering data from situations where IWM advanced for three days, in 274 of 319 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.

IWM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Notable companies

The most notable companies in this group are Transocean Ltd (NYSE:RIG), Lumen Technologies (NYSE:LUMN), Abercrombie & Fitch Co (NYSE:ANF), Valaris Limited (NYSE:VAL), Adaptive Biotechnologies Corp (NASDAQ:ADPT), California Resources Corp (NYSE:CRC), Fastly (NASDAQ:FSLY), Scorpio Tankers (NYSE:STNG), Tanger (NYSE:SKT), Bread Financial Holdings (NYSE:BFH).

Industry description

The investment seeks to track the investment results of the Russell 2000® Index, which measures the performance of the small-capitalization sector of the U.S. equity market. The underlying index is a float-adjusted capitalization-weighted index of equity securities issued by the approximately 1,933 smallest issuers in the Russell 3000 Index. The fund may use derivatives to gain or reduce exposure to the components of the underlying index or exposure to one or more market risk factors associated with such components.

Market Cap

The average market capitalization across the iShares Russell 2000 ETF (IWM) ETF is 2.29B. The market cap for tickers in the group ranges from 34.1M to 12.52B. HUT holds the highest valuation in this group at 12.52B. The lowest valued company is CNTX at 34.1M.

High and low price notable news

The average weekly price growth across all stocks in the iShares Russell 2000 ETF (IWM) ETF was 76%. For the same ETF, the average monthly price growth was 256%, and the average quarterly price growth was 721%. SRZN experienced the highest price growth at 99%, while CMPX experienced the biggest fall at -39%.

Volume

The average weekly volume growth across all stocks in the iShares Russell 2000 ETF (IWM) ETF was -3%. For the same stocks of the ETF, the average monthly volume growth was 16% and the average quarterly volume growth was -23%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 55
P/E Growth Rating: 56
Price Growth Rating: 54
SMR Rating: 71
Profit Risk Rating: 77
Seasonality Score: -16 (-100 ... +100)
View a ticker or compare two or three
IWM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category SmallBlend

Category
Small Blend
Address
iShares Trust400 Howard StreetSan Francisco
Phone
415-670-2000
Web
www.ishares.com
Interact to see
Advertisement
INSM shares are surging approximately +10% in premarket trading on Monday, March 23, 2026, from a prior close of $136.00, placing the premarket price near $149.60. The primary catalyst is the release of positive topline results from the Phase 3 ENCORE trial of ARIKAYCE® in patients with newly diagnosed or recurrent MAC (Mycobacterium avium complex) lung disease — a readout Insmed had flagged as expected in "March or April 2026".
CF shares are trading approximately -6% lower in Monday's premarket session, dropping from a Friday close of $124.90 to approximately $117.41. Primary catalyst: President Trump announced a five-day pause on strikes against Iranian energy infrastructure following "very good" diplomatic signals, triggering a sharp unwind of the geopolitical risk premium embedded in fertilizer stocks.
APGE shares surged approximately 16% in premarket trading on March 23, 2026, after the company announced positive 52-week data from Part A of its Phase 2 APEX clinical trial. The primary catalyst is a highly anticipated clinical readout showing that zumilokibart (APG777) delivered durable and deepening responses in patients with moderate-to-severe atopic dermatitis at both every 3-month and 6-month dosing intervals.
Shares of VALN are plummeting approximately 35% in Monday's session, from a Friday close of $10.66 to roughly $6.93, in heavy volume trading. The primary catalyst is the release of Phase 3 VALOR trial topline results for Valneva's Lyme disease vaccine candidate, co-developed with PFE (Pfizer) — results that showed strong clinical efficacy but failed to meet the pre-determined statistical criterion for the primary endpoint.
AXTI is surging approximately +11.00% in Monday's session, trading near $60.21, up from a prior closing price of $54.24. The move extends the stock's post-earnings rally that began last Thursday when shares jumped more than 19% following AXT's Q4 2025 results.
Tower Semiconductor (TSEM) shares are surging approximately +10% intraday on Monday, March 23, trading around $180, up from the previous close of $163.63 on March 20, 2026. The primary catalyst is the opening day of APEC 2026 in San Antonio, Texas, where Tower Semiconductor is presenting its newly unveiled Gen3 BCD power management platform designed to address escalating AI data center power demands.
CD is indicated down about 17% in premarket trading after the latest completed session, pointing to a sharp negative market reaction heading into the open. The stock’s weakness comes against a backdrop of lingering uncertainty following its privatization and delisting process from Nasdaq, which has left limited liquidity and a thinner news flow around the name.
SEDG is indicated down roughly 9% in premarket trading, following a strong advance in the prior regular session. The pullback comes after shares rallied on optimism around new product launches and an analyst upgrade, leaving the stock vulnerable to profit-taking and volatility.
NTGR shares surged approximately 11% in premarket trading on March 24, 2026, building on a roughly 20% overnight jump in the prior session. The primary catalyst is a landmark Federal Communications Commission (FCC) ruling that prohibits all imports of consumer routers manufactured overseas, citing national security concerns.
ANNA is surging approximately +20.00% in Tuesday's premarket session, rebounding sharply from Monday's -22.84% decline. The primary catalyst remains the ongoing U.S.-Iran military conflict, which disrupted Qatari LNG exports and drove European benchmark natural gas prices to multi-year highs.
Concentrix Corporation (CNXC) shares are falling approximately 11% in Tuesday's premarket session after the company released its fiscal Q1 2026 earnings report before market open. Adjusted diluted EPS came in at $2.61, missing the Wall Street consensus estimate of approximately $2.64.
Shares of Karyopharm Therapeutics (KPTI) are trading approximately 12% lower in Tuesday's premarket session, with the previous close at $7.63. The primary catalyst is the March 24 release of topline Phase 3 SENTRY trial data, in which the company met only one of two co-primary endpoints.
IBRX shares are down approximately 23% in Tuesday's session, trading near $7.24 after closing at $9.40 on Monday, March 23. The sharp decline follows an 11%+ surge in the prior session, with profit-taking and valuation pressure cited as primary triggers.
Shares of Circle Internet Group (CRCL) are down approximately 9% in Tuesday morning trading, extending a pullback from recent multi-month highs above $126. The primary catalyst appears to be a broad crypto-sector risk-off wave, with Bitcoin sliding below $69,000 and the Fear & Greed Index dropping to extreme fear territory.
ALM shares are indicated down about 11% in early Tuesday trading after closing the prior session at $16.93. The move comes after a powerful multi‑month rally that took the stock from below $3 to an intraday high of $22.55 earlier in March, leaving it vulnerable to profit-taking and volatility.​
LUNR shares are indicated down about 7% in Tuesday premarket trading after closing the last regular session at $20.31. The pullback follows a powerful rally driven by strong 2026 revenue guidance of $900 million–$1 billion and upbeat analyst commentary, including price target hikes and buy ratings.
MAZE shares are trading approximately 27% lower in premarket on March 25, 2026, after the company reported its highly anticipated Phase 2 HORIZON trial topline data for lead drug candidate MZE829. The catalyst is a dual announcement: Phase 2 clinical data for MZE829 in APOL1-mediated kidney disease (AMKD) alongside Q4 and full-year 2025 financial results.
ARM shares surged approximately +10% in premarket trading on March 25, 2026, hitting $148.6 from a prior close of approximately $135. The primary catalyst is Arm's historic strategic pivot: the company announced it will begin selling its own self-developed AGI CPU chips, breaking its decades-long "IP licensing only" business model.
Shares of Enliven Therapeutics (ELVN) are surging approximately +15% in premarket trading on March 25, 2026, driven by renewed investor enthusiasm around the company's advancing clinical program for ELVN-001 in chronic myeloid leukemia (CML). The stock's prior closing price on March 24, 2026 was $31.15, placing the premarket indicated price near $35.82.
AVXL shares are down approximately 29% in premarket trading on Wednesday, March 25, 2026, falling to roughly $2.97 from the prior close of $4.19. The primary catalyst is Anavex's formal withdrawal of its marketing authorization application (MAA) for blarcamesine from the European Union, announced in the early hours of March 25, 2026.